The stability of the retained austenite has been studied in situ in low-alloyed transformation-induced-plasticity (TRIP) steels using high-energy X-ray diffraction during tensile tests at variable temperatures down to 153 K. A detailed powder diffraction analysis has been performed to probe the austenite-to-martensite transformation by characterizing the evolution of the phase fraction, load partitioning and texture of the constituent phases simultaneously. Our results show that at lower temperatures the mechanically induced austenite transformation is significantly enhanced and extends over a wider deformation range, resulting in a higher elongation at fracture. Low carbon content grains transform first, leading to an initial increase in average carbon concentration of the remaining austenite. Later the carbon content saturates while the austenite still continues to transform. In the elastic regime the probed {h k l} planes develop different strains reflecting the elastic anisotropy of the constituent phases. The observed texture evolution indicates that the austenite grains oriented with the {2 0 0} plane along the loading direction are transformed preferentially as they show the highest resolved shear stress. For increasing degrees of plastic deformation the combined preferential transformation and grain rotation results in the standard deformation texture for austenite with the {1 1 1} component along the loading direction. The mechanical stability of retained austenite in TRIP steel is found to be a complex interplay between carbon concentration in the austenite, grain orientation, load partitioning and temperature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.